Article
Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene.
Carcinogenesis - 1 Jul 1996
Wessner L L, Fan M, Schaeffer D O, McEntee M F, Miller M S
Abstract excerpt
A pharmacogenetic mouse model was utilized to determine the role of Cyp1a1 expression on the formation of Ki-ras mutations in lung tumors following transplacental exposure to polycyclic aromatic hydrocarbons (PAHs). A backcross between Ah responsive male B6D2F1 mice and nonresponsive female DBA mice resulted in a litter in which both responsive and nonresponsive fetuses resided in the same nonresponsive maternal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
